UCSF alumnus Stephen Hode, M.D. '03

Turns out, designing a COVID vaccine was easy

The hard part was everything that came next, says UCSF alum Stephen Hoge, president of Moderna

Nurse operating dialysis machine next to a woman

Prolonging life for those on dialysis

A $3M National Institutes of Health grant to three UC campuses will seek to improve survival rates for patients on dialysis.

Blood testing a hand

A cellular culprit for Type 1 diabetes

Researchers have identified a predictive causal role for specific cell types in the condition, which affects more than 1.6 million Americans.

Ronke Olabisi

Helping humans heal

Ronke Olabisi is working on a cell regenerative therapy with potential applications in chronic wounds, burns and aging.

MRI of glioblastomas

Immunotherapy for hard-to-treat cancers ready to move toward clinical trials

Researchers have demonstrated how to engineer smart immune cells that are effective against solid tumors.

Cloud from a wildfire over a hill near Santa Cruz

Wildfire smoke linked to skin disease in first-of-its-kind study

A new study suggests that the dangers posed by wildfire smoke may also extend to the largest organ in the human body: the skin.

Woman in mask looks out the window

For COVID-19 long-haulers, few answers, but meditation and peer support offer some relief

As scientists try to understand lingering COVID-19 health issues, a new program hopes to give patients better tools to cope with the debilitating symptoms.

Jackie Robinson signing autographs at a game

Did racism kill Jackie Robinson?

Jackie Robinson integrated Major League Baseball over 70 years ago, breaking down barriers for future generations. Now, scientists ask — did racism lead to Robinson's early death?

Tailocins on bacteria digital visualization

The incredible bacterial ‘homing missiles’ that scientists want to harness

A Berkeley Lab-led team is digging into bacteria-produced nanomachines that could fast-track microbiome science.

Young Black woman in hospital room

FDA approves first test of CRISPR to correct genetic defect causing sickle cell disease

UC scientists and physicians hope to permanently cure patients of sickle cell disease by using CRISPR-Cas9 to replace a defective gene with the normal version.